Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
出版年份 2009 全文链接
标题
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 284, Issue 35, Pages 23502-23516
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2009-07-04
DOI
10.1074/jbc.m109.012393
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation
- (2010) Zhongqi Zhang et al. PROTEIN SCIENCE
- Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells
- (2009) Brigitte Rigat et al. MOLECULAR GENETICS AND METABOLISM
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Gaucher disease: improving management
- (2008) Bruno Bembi et al. ACTA PAEDIATRICA
- The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations
- (2008) Ozlem Goker-Alpan et al. ARCHIVES OF NEUROLOGY
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
- (2008) Jin-Song Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Isofagomine Induced Stabilization of Glucocerebrosidase
- (2008) Gregory J. Kornhaber et al. CHEMBIOCHEM
- Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry
- (2008) Michael B. Tropak et al. CHEMBIOCHEM
- Ambroxol: A CNS Drug?
- (2008) Thomas Weiser CNS Neuroscience & Therapeutics
- Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosis
- (2008) William Boston-Howes et al. EXPERIMENTAL NEUROLOGY
- Ambroxol in the 21st century: pharmacological and clinical update
- (2008) Mario Malerba et al. Expert Opinion on Drug Metabolism & Toxicology
- Treatment perspectives for the lysosomal storage diseases
- (2008) Gregory A Grabowski EXPERT OPINION ON EMERGING DRUGS
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
- Fully Automated Molecular Mechanics Based Induced Fit Protein−Ligand Docking Method
- (2008) Jürgen Koska et al. Journal of Chemical Information and Modeling
- Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring
- (2008) T. M. Cox et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease
- (2008) Maria Fuller et al. MOLECULAR GENETICS AND METABOLISM
- Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis
- (2008) Douglas R. Martin et al. MOLECULAR GENETICS AND METABOLISM
- Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
- (2008) Naoki Masuda et al. NEUROBIOLOGY OF DISEASE
- Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
- (2008) Z. Gan-Or et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started